Castle Biosciences officer proposes $148K share sale
The proposed shares are associated with a cash exercise of stock options with the issuer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Castle Biosciences Inc. (CSTL) lists a proposed sale by officer Kristen Oelschlager of 4,153 common shares, with Morgan Stanley Smith Barney LLC named as broker and October 1, 2026 as the approximate sale date. The related securities information gives an aggregate market value of $147,556.09 and describes the shares as tied to a cash exercise of stock options with the issuer.
Key Figures
Key Terms
Rule 144 regulatory
10b5-1 Sales regulatory
Exercise of Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.